Mirvie
5 known investors
Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical. The platform serves pregnant women and their healthcare providers to improve maternal and fetal health outcomes.
Investors · 5
In the news
- Mirvie Inc. raises $23.7M: offering $30M: Form Dainvest.com · 2025
- Biotech Company Mirvie Raises $60M for Its RNA Platform Focused on Early Prediction of Pregnancy Complications | Femtech Insiderfemtechinsider.com · 2022
- Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complicationsforbes.com · 2022
- Wilson Sonsini Advises Mirvie on $60 Million Series B | Wilson Sonsiniwsgr.com · 2022
- Mirvie Raises $60 Million Funding Round to Shape the Future of Pregnancy Healthbusinesswire.com · 2022
- Mirvie - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021